Announcement: Call for Papers: Vol. 1, No. 2

PiscoMed Publishing Pte Ltd and the Editor-in-chief, Dr. Omar Abdel-Rahman, invite all authors to submit their manuscripts to our newly launched journal, Advances in Modern Oncology Research (AMOR), for peer review.


AMOR is an open access journal that allows immediate visibility and access for research outputs as well as free usage of researchers’ results. As the Journal is entitled Advances in Modern Oncology Research, some relevant topics include but are not limited to:

  • Breast cancer
  • Thoracic malignancies (including lung cancer, mesothelioma and thymoma).
  • Genitourinary cancer (including kidney cancer, prostate cancer and bladder cancer)
  • GI cancer (including colorectal cancer, gastroesophageal cancer, hepato-pancreato-biliary cancer)
  • Hematological malignancies(including lymphoma, myeloma and leukemia)
  • Endocrine cancer
  • Head and neck cancer


The journal is well-defined in rendering support to authors, including how:

  • Authors may maintain their copyright.
  • The articles can be shared, re-used, and archived without cost.
  • Being consistent with important open access guidelines, the Journal is a compelling addition to the latest archiving procedures.
  • Immediate processing refers to publication in minimum time. All editorial and publication work are directed towards high-quality results.


Submission can be made through the “Submit Your Manuscript” icon on the journal home page. By clicking on this, you will be directed to the Online Submission page and Author Guidelines. Alternatively, you may click on this hyperlink:


Authors should adhere to basic requirements, including word count. You will find the Manuscript Submission Template (download) in Word document extremely useful. Following this, you can upload your manuscript for peer-review.


All manuscripts will go through rigorous peer-reviews. Each manuscript will be reviewed by two academically qualified reviewers from the Editorial Board or from external links, and the Editor-in-Chief. To keep the Journal wide in scope and unrestrictive, we will generally be accepting manuscripts from different countries and from different authors. The decision regarding the outcome of manuscripts for publication will be determined by the Editor-in-chief.


All operational outcomes will be performed by PiscoMed’s dedicated editorial office to meet high degrees of efficiency and proper deadline administration. Hence, the author can follow through all necessary tasks promptly.


Once you have submitted your manuscript, you can access it regularly by signing in live to the manuscript management system with your user name and password to monitor the progress of your submission. Advantageous to authors is the fact that no fees will be charged in cases of non-publication. Where the manuscript is accepted for publication, a fee of US$500 per article will apply. Manuscripts submitted to the second issue will be published with 50% discount.


If you have questions regarding the criteria or if you encounter any difficult during submission, simply contact the AMOR editorial office at